Skip Navigation


JAC Advance Access originally published online on April 29, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
53/6/936    most recent
dkh200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Winnock, M.
Right arrow Articles by Chêne, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winnock, M.
Right arrow Articles by Chêne, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2004) 53, 936-946
© 2004 The British Society for Antimicrobial Chemotherapy

Review

Interaction between HIV-1 and HCV infections: towards a new entity?

Maria Winnock1,*, Dominique Salmon-Céron2, François Dabis1 and Geneviève Chêne1

1 INSERM U593, Université Victor Ségalen, 146 rue Léo Saignat, 33076 Bordeaux; 2 Department of Internal Medicine, Hôpital Cochin, Paris, France

Since human immunodeficiency virus (HIV) and hepatitis C virus (HCV) share the same modes of transmission, HIV–HCV co-infected patients are relatively common. Until recently, the clinical course of HCV in co-infected patients was overshadowed by the high morbidity and mortality of HIV disease. Recent reductions in morbidity and mortality among HIV-infected patients due to the advent of highly active antiretroviral therapy (HAART), have contributed to the emergence of HCV as a significant viral pathogen in this population. This article reviews the current evidence on the epidemiology and clinical implications of an interaction between HIV-1 and HCV infections.

Keywords: prevalence, epidemiology, fibrosis, liver, HAART

* Corresponding author. Tel: +33-5-57-57-13-93; Fax: +33-5-57-57-11-72; E-mail: Maria.Winnock{at}isped.u-bordeaux2.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Journal of Pharmacy PracticeHome page
K. McNelis
Management of Hepatitis C Infection in the HIV-Infected Patient
Journal of Pharmacy Practice, February 1, 2006; 19(1): 37 - 52.
[Abstract] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.